First Capital Advisors Group, Llc. Alnylam Pharmaceuticals, Inc. Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 423 shares of ALNY stock, worth $107,755. This represents 0.04% of its overall portfolio holdings.
Number of Shares
423Holding current value
$107,755% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
586Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.26 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$3.06 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.3 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.84 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.69 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...